Yagi Kazuma, Ito Akihiro, Fujiwara Keiji, Morino Eriko, Hase Isano, Nakano Yasushi, Asakura Takanori, Furuuchi Koji, Morita Atsuho, Asami Takahiro, Namkoong Ho, Saito Fumitake, Morimoto Kozo, Ishii Makoto, Sato Yasunori, Tateno Hiroki, Nishio Kazumi, Oyamada Yoshitaka, Fukunaga Koichi, Sugiyama Haruhito, Ishida Tadashi, Kurashima Atsuyuki, Hasegawa Naoki
Division of Pulmonary Medicine, Department of Medicine.
Department of Respiratory Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Ann Am Thorac Soc. 2021 Sep;18(9):1490-1497. doi: 10.1513/AnnalsATS.202008-938OC.
The clinical features and prognosis of nontuberculous mycobacterial (NTM) pleuritis and pleural effusion combined with NTM lung disease remain unclear. To investigate the clinical features and prognosis of NTM pleuritis. This retrospective observational study included patients with NTM pleuritis from January 2001 to June 2018 across eight hospitals in Japan. NTM pleuritis was defined by a positive NTM culture of pleural effusion samples. We matched patients with complex (MAC) lung disease (MAC-LD) without pleuritis by sex and age to obtain comparative data and investigated the association between clinical parameters and the prognosis. We identified 64 patients with NTM pleuritis (median age, 73 yr; 37 female patients). The median follow-up duration was 11 months, and 27 patients died. Patients with MAC pleuritis had a significantly lower survival rate than matched patients with MAC-LD without pleuritis. Multivariate analysis revealed that pleuritis (adjusted hazard ratio, 6.99; 95% confidence interval [CI], 2.58-19.00) and underlying pulmonary diseases (adjusted hazard ratio, 3.01; 95% CI, 1.44-6.28) were independently associated with all-cause mortality in patients with MAC-LD. The prognosis of MAC pleuritis is poorer than that of MAC-LD without pleuritis. Pleuritis is an independent prognostic factor in patients with MAC-LD.
非结核分枝杆菌(NTM)胸膜炎以及胸腔积液合并NTM肺病的临床特征和预后仍不明确。为了研究NTM胸膜炎的临床特征和预后。这项回顾性观察性研究纳入了2001年1月至2018年6月期间日本8家医院的NTM胸膜炎患者。NTM胸膜炎通过胸腔积液样本的NTM培养呈阳性来定义。我们按性别和年龄将NTM胸膜炎患者与无胸膜炎的复杂性(MAC)肺病(MAC-LD)患者进行匹配以获取比较数据,并研究临床参数与预后之间的关联。我们确定了64例NTM胸膜炎患者(中位年龄73岁;37例女性患者)。中位随访时间为11个月,27例患者死亡。MAC胸膜炎患者的生存率明显低于匹配的无胸膜炎的MAC-LD患者。多变量分析显示,胸膜炎(调整后的风险比,6.99;95%置信区间[CI],2.58-19.00)和潜在肺部疾病(调整后的风险比,3.01;95%CI,1.44-6.28)与MAC-LD患者的全因死亡率独立相关。MAC胸膜炎的预后比无胸膜炎的MAC-LD更差。胸膜炎是MAC-LD患者的独立预后因素。